MSR119 Assessing the Impact of PD-L1 and BRAF Biomarkers on Long-Term Survivorship (LTS) Rates Among Treatment-Naive Advanced Melanoma Patients Receiving Immune Checkpoint Inhibitors (ICIs)
Abstract
Authors
Murat Kurt Paul Serafini Victoria Wan Mir Sohail Fazeli Jean-Paul Collet